Menu

Generics/Research

Canada EU V13J31

Right of appeal provision in CETA

Generics/Research | Posted 14/08/2014

The Comprehensive Economic and Trade Agreement (CETA) between the European Union (EU) and Canada has the potential to have a negative affect on the generics industry in Canada [1], with certain provisions being seen as causing the most harm.

136 AA011035

Data protection provisions in CETA

Generics/Research | Posted 01/08/2014

The trade agreement between the European Union (EU) and Canada has the potential to have a negative affect on the generics industry in Canada [1]. In particular, certain intellectual property provisions are seen as the main culprits.

24 AA011041

Patent term restoration provisions in CETA

Generics/Research | Posted 04/07/2014

Some of the provisions included in the Comprehensive Economic and Trade Agreement (CETA) between the European Union (EU) and Canada are seen as having the potential to have a negative affect on the generics industry in Canada [1].

picture 84

Influence of CETA on generics

Generics/Research | Posted 27/06/2014

On 18 October 2013, the European Union (EU) and Canada reached a political agreement on the key elements for a Comprehensive Economic and Trade Agreement (CETA). However, CETA has been criticized for the fact that it affects intellectual property rights in Canada, but not the EU. Some of the provisions included in the agreement are seen as having the potential to have a negative affect on the generics industry in Canada.

picture 110

Factors influencing use of generic asthma drugs in Morocco

Generics/Research | Posted 20/06/2014

Despite the introduction of methods to promote the use of generics, use of generic anti-asthmatic drugs remains limited in Morocco. The Moroccan market therefore remains largely dominated by patent-protected originator drugs [1].

picture27

Promoting generics prescribing in the UK

Generics/Research | Posted 13/06/2014

Possible ways to encourage more prescribing of generics in the UK include financial incentives with educational intervention and audit/feedback, according to a review of data on prescribing behaviour [1].

picture 79

Impact of price cuts on spending on hyperlipidaemic drugs in South Korea

Generics/Research | Posted 06/06/2014

Rapidly increasing pharmaceutical expenditures have become a constant challenge to the sustainability of healthcare systems across countries including Korea.

picture04

Generic atypical antipsychotic drugs in Belgium

Generics/Research | Posted 02/06/2014

Health authorities are continually looking to increase the utilization of low cost generics to save considerable monies without compromising care, given the ever increasing pressure on available resources. Pressures are driven by ageing populations, the continual launch of new premium-priced drugs and stricter clinical management targets. The quest is enhanced by the number of standard drugs losing their patents in recent years.

picture 118

Impact of delisting ARBs in Denmark

Generics/Research | Posted 23/05/2014

Health authorities are looking to increase the utilization of low cost generics to save considerable resources without compromising care. This includes Denmark [1].

picture 70

Pharmacists’ attitudes towards generics in Czech Republic

Generics/Research | Posted 16/05/2014

A study carried out in the Czech Republic found that whether pharmacists routinely carried out generics substitution depended on their familiarity with the relevant legislation and their attitude towards generics substitution [1].

122 MD002454

Attitudes towards generics in Turkey

Generics/Research | Posted 02/05/2014

Prescribers, pharmacists and patients in Turkey lack knowledge about generics. They may also be misinformed about generics, which can cause hesitation about the use of these drugs, according to Toklu and co-authors from the University of Istanbul, Turkey [1].

ANDA Approval V13F21

Free samples increase use of branded drugs

Generics/Research | Posted 25/04/2014

The practice of giving free samples to physicians to give out to their patients increases the use of brand-name drugs, according to research published in JAMA Dermatology [1].

picture59

Positive impact of a value-based approach to health care

Generics/Research | Posted 18/04/2014

A study into the use of value-based benefit design (VBBD) for members of an employee health benefits programme demonstrated that such a programme can have a positive impact on adherence and cost outcomes [1].

Patient MD002316 V13C05

Prescribers, pharmacists and patients in Turkey believe generics differ from originators

Generics/Research | Posted 04/04/2014

A study carried out by Toklu and co-authors from the University of Istanbul, Turkey, has shown that many prescribers, pharmacists and patients in Turkey believe that generics differ from their originators [1].

109 MD002387

The non-financial benefits of generics substitution

Generics/Research | Posted 28/03/2014

Switching between different generic brands of metformin is a good cost-effective approach that does not adversely affect the quality of care for patients with type 2 diabetes, according to the results of a retrospective study in Taiwan.

Pay for Delay DrugsMoneyGeneric V13F21

Generics contribution to availability of essential medicines

Generics/Research | Posted 14/03/2014

The creation of Essential Medicines Lists (EMLs) within country healthcare systems is promoted by the World Health Organization (WHO) in order to improve the availability and use of medicines considered essential.

28 MD002360

Use of generic cardiovascular drugs in China

Generics/Research | Posted 07/03/2014

China has not yet recognized the importance of increasing generics use as a method to reduce drug prices. An analysis of drug prices in hospitals in the Chongqing province in China has shown that there are potentially major savings to be made by increasing the volume of generics used in China [1].

Generic Brand Name V13C01

Compliance and persistence same for generic and brand-name alendronate

Generics/Research | Posted 28/02/2014

A retrospective analysis of data in Italy has shown that patients taking generic and brand-name alendronate showed the same rates of persistence and compliance [1].

88 MD002468

Confusion exists in Brazil over generics

Generics/Research | Posted 21/02/2014

Brazilians are confused about generics and are unable to distinguish between a generic drug and a brand-name drug [1].

picture 122

Impact of coupons on adherence to statins

Generics/Research | Posted 14/02/2014

Once patents expire, in an effort to maintain market share, originator manufacturers often initiate promotional activities such as drug samples and co-pay discount coupons that reduce patients out-of-pocket costs associated with the purchase of brand-name drugs.